Sermorelin
Muscle/RecoveryGrowth Hormone Releasing
GHRH analog for GH research.
For research use only.
Key Facts
- CAS
- 86168-78-7
- Molecular Weight (MW)
- 3357.96 g/mol
- Half-life
- ~11-12 minutes
- Unit
- mcg
- Administration Route
- Subcutaneous
- Frequency
- Daily
- Last updated
- 12/18/2025
- Targets
- Pituitary GHRH receptors
Overview
GHRH analog for GH research.
Protocol
- Dosage Range
- 200-300 mcg
- Frequency
- Daily
- Cycle
- 12-16 weeks on, 4-6 off
- Administration Route
- Subcutaneous
- Reconstitution Guide
- 3 mL BAC for 5 mg vial
Science
Mechanism of Action
Stimulates pulsatile GH release.
Targets
Pituitary GHRH receptors
Studies
- — Journal/year not available
Benefits
GH supportAnti-agingRecoveryBody composition
Potential Side Effects
- Irritation
- Headache
- Flushing
References
Related peptides
5-Amino-1MQ
Fat Loss
View details →CJC-1295 (no DAC) + Ipamorelin
Muscle/Recovery
View details →Delta Sleep-Inducing Peptide (DSIP)
Muscle/Recovery
View details →Epitalon
Longevity
View details →Glow (GHK-Cu / BPC-157 / TB-500)
Muscle/Recovery
View details →KLOW (GHK-Cu / KPV / BPC-157 / TB-500)
Muscle/Recovery
View details →